GSK announces positive results from GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus (relentless itch) associated with PBC: London, UK Wednesday, Novembe ...

Glamour magazine sought clarity from Dr Donald Grant, a GP and Senior Clinical Advisor at The Independent Pharmacy, who ...

Itchy breasts and nipples can be an uncomfortable experience that disrupts daily life. While occasional itching may seem ...

There are dermatologists who don’t have much training in vulvar dermatology, and a lot of gyns don’t get as much training” as ...

Significant correlation shown between blood levels and symptom relief; TH104 was well tolerated with no unexpected ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024PARIS, FRANCE, 18 ...

The latest news and information from Costa Rica including breaking news, weather, travel, events, sports and more.

The NHS is urging people to use the Pharmacy First scheme as it can help save time and money - and there are seven conditions ...

Otitis externa is one of the most common conditions clinicians encounter, particularly in dogs with allergic skin disease.

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...

The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...